Source: Journal of Acquired Immune Deficiency Syndromes. Unidade: FMRP
Subjects: INFECÇÕES POR HIV, FARMACOTERAPIA, FARMACOCINÉTICA, MULHERES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Carolina Sales et al. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. Journal of Acquired Immune Deficiency Syndromes, v. 66, n. 4, p. 378–385, 2014Tradução . . Disponível em: https://doi.org/10.1097/QAI.0000000000000189. Acesso em: 29 set. 2024.APA
Vieira, C. S., Bahamondes, M. V., Souza, R. M. de, Brito, M. B., Prandini, T. R. R., Amaral, E., et al. (2014). Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. Journal of Acquired Immune Deficiency Syndromes, 66( 4), 378–385. doi:10.1097/QAI.0000000000000189NLM
Vieira CS, Bahamondes MV, Souza RM de, Brito MB, Prandini TRR, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women [Internet]. Journal of Acquired Immune Deficiency Syndromes. 2014 ; 66( 4): 378–385.[citado 2024 set. 29 ] Available from: https://doi.org/10.1097/QAI.0000000000000189Vancouver
Vieira CS, Bahamondes MV, Souza RM de, Brito MB, Prandini TRR, Amaral E, Bahamondes L, Duarte G, Quintana SM, Scaranari C, Ferriani RA. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women [Internet]. Journal of Acquired Immune Deficiency Syndromes. 2014 ; 66( 4): 378–385.[citado 2024 set. 29 ] Available from: https://doi.org/10.1097/QAI.0000000000000189
